← Open Payments lookup

EMILY CARPENTIER: Open Payments

NPI 1700591534 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,336 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $1,336

Food & beverage: $1,336
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc8$623
ORPHALAN INC1$150
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$142
Mallinckrodt Hospital Products Inc.1$121
Gilead Sciences, Inc.1$112
ABBVIE INC.2$38
Novo Nordisk Inc1$35
Lilly USA, LLC1$33
Alexion Pharmaceuticals, Inc.1$27
Merck Sharp & Dohme LLC1$19

Products named: IQIRVO, CUVRIOR, XIFAXAN, TERLIVAZ, Livdelzi, MAVYRET, Ozempic, MOUNJARO.

Industry payments across CO — which companies pay providers there.